Our Commitment to Stem Cell Research & Safety

Our Commitment to Stem Cell Research & Safety

While the California Stem Cell Treatment Center aims to provide our patients with the most personalized cellular medical care available, we felt it was paramount to demonstrate that the surgery we practice is first and foremost safe.

 

The founders of the California Stem Cell Treatment Center, Dr. Berman and Dr. Lander, are proud to have published one of the largest safety data papers on the use of autologous stromal vascular fraction (SVF) to date, including intravenous infusions.

 

This paper comes from the work of physicians around the globe, their dedication to our institutional review board-approved processes, and their work in tracking patient outcomes through our network-wide database.

 

This effort, which has been underway for over 10 years now, has led us to publish over 12 peer-reviewed publications, the largest of their respective kind, documenting safety and efficacy in orthopedics, urology, neurology, and pain management, which are featured below.

 

Doctors Berman and Lander have also written textbook chapters on regenerative medicine and have spoken at high level medical meetings all over the world.

 

Today we are proud to provide our patients with safe and ethical stem cell therapy treatments in Beverly Hills and Rancho Mirage, CA.

 

We continue to make many advances in our research, aggregating patient data and outcomes network-wide, consistently advancing cellular medicine along the way.

Publications

SVF Safety Data Paper
SVF Safety Data Paper
SVF For Chronic Pain
SVF For Chronic Pain
SVF for Knee Osteoarthritis
SVF for Knee Osteoarthritis
SVF and Intracerebro-ventricular Injections for Neuro-degenerative Disorders
SVF and Intracerebro-ventricular Injections for Neuro-degenerative Disorders
Ratio of ADSC to HSC to Predict Outcomes
Ratio of ADSC to HSC to Predict Outcomes
SVF Review
SVF Review
SVF for TBI Laboratory Study
SVF for TBI Laboratory Study
Delivery of oncolytic vaccinia virus
Delivery of oncolytic vaccinia virus
SVF for Interstitial Cystitis
SVF for Interstitial Cystitis
First‑in‑human study of TK‑positive oncolytic vaccinia virus delivered by SVF
First‑in‑human study of TK‑positive oncolytic vaccinia virus delivered by SVF
SVF and Shock Wave for Erectile Dysfunction
SVF and Shock Wave for Erectile Dysfunction
SVF and Shockwave Therapy
SVF and Shockwave Therapy

Publications

SVF Safety Data Paper
SVF Safety Data Paper
SVF For Chronic Pain
SVF For Chronic Pain
SVF for Knee Osteoarthritis
SVF for Knee Osteoarthritis
SVF and Intracerebro-ventricular Injections for Neuro-degenerative Disorders
SVF and Intracerebro-ventricular Injections for Neuro-degenerative Disorders
Ratio of ADSC to HSC to Predict Outcomes
Ratio of ADSC to HSC to Predict Outcomes
SVF Review
SVF Review
SVF for TBI Laboratory Study
SVF for TBI Laboratory Study
Delivery of oncolytic vaccinia virus
Delivery of oncolytic vaccinia virus
SVF for Interstitial Cystitis
SVF for Interstitial Cystitis
First‑in‑human study of TK‑positive oncolytic vaccinia virus delivered by SVF
First‑in‑human study of TK‑positive oncolytic vaccinia virus delivered by SVF
SVF and Shock Wave for Erectile Dysfunction
SVF and Shock Wave for Erectile Dysfunction
SVF and Shockwave Therapy
SVF and Shockwave Therapy